Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Identification of Epigenetic Modifiers Essential for Growth and Survival of AML1/ETO-Positive Leukemia

Jesus Duque Afonso, Veratti Pia, Usama-Ur Rehman, Heike Herzog, Jan Mitschke, Gabriele Greve, Julian Eble, Bettina Berberich, Johanna Thomas, Milena Pantic, Miguel Waterhouse, Gaia Gentile, Olaf Heidenreich, Cornelius Miething, Michael Lübbert

Blood (2023) 142 (Supplement 1): 5687.

https://doi.org/10.1182/blood-2023-187372

Published: 2023

Journal Articles

The Fanconi Anemia-Associated Protein NIPA Is Essential for the Nuclear Abundance of FANCD2

Blood (2019) 134 (Supplement_1): 3741.

https://doi.org/10.1182/blood-2019-125973

Published: 2019

Journal Articles

Minimal Residual Disease (MRD) Analysis Using Multiparametric Flow Cytometry (MFC) and Identification of Differences in Subpopulations Using Next Generation Sequencing (NGS) in the Bone Marrow (BM) of Multiple Myeloma (MM) Patients (pts)

Sandra M. Dold, MSc, BSc, Veronika Riebl, Dagmar Wider, Marie Follo, PhD, Stefan J. Mueller, Ingrid Bartsch, Milena Pantic, PhD, Cornelius Miething, MD, Chrissoula Kiote-Schmidt, K. Martin Kortüm, MD, Mihaela Zlei, Abdel Kareem Azab, PhD, Mascha Binder, MD, Justyna Rawluk, Justus Duyster, Prof., Robert Zeiser, MD, Ralph Wäsch, MD, Monika Engelhardt, MD

Blood (2018) 132 (Supplement 1): 3222.

https://doi.org/10.1182/blood-2018-99-112489

Published: 2018

Journal Articles

Implantation of Patient-Derived Acute Leukemia Cells into the Hematopoietic Niche of Immunocompromised Mice Favors Faithful Recapitulation of the Disseminated Growth of Human Leukemia

Julia Schueler, DVM, PhD, Gabriele Greve, Dorothee Lenhard, Kerstin Klingner, Milena Pantic, PhD, Eva Oswald, PhD, Michael Lubbert, MD

Blood (2017) 130 (Supplement 1): 1427.

https://doi.org/10.1182/blood.V130.Suppl_1.1427.1427

Published: 2017

Journal Articles

Identification of a Novel Chromosomal Translocation t(11;16)(q23;q22) Fusing MLL to Enhancer of mRNA Decapping (EDC)-4 in Smoldering Acute Myeloid Leukemia

Heiko Becker, MD, Keisuke Kataoka, MD PhD, Gabriele Greve, Jesús Duque Afonso, MD, Tobias Ma, Sabine Bleul, Milena Pantic, PhD, Julia Schüler, DVM, PhD, Justus Duyster, MD, Michael L Cleary, MD, Seishi Ogawa, MD PhD, Michael Lübbert, MD

Blood (2016) 128 (22): 1696.

https://doi.org/10.1182/blood.V128.22.1696.1696

Published: 2016

Journal Articles

Results of an Open, Non-Comparative, Phase I/II Investigator Initiated Trial (IIT) in Relapsed or Refractory Multiple Myeloma Patients Using Vorinostat, Bortezomib, Doxorubicin and Dexamethasone (VBDD)

Alexander Keller, MD, Johannes M. Waldschmidt, MD, Dagmar Wider, Dorothee Jakobs, Mandy Möller, Heike Reinhardt, Milena Pantic, PhD, Olga Grishina, MD, Gabriele Ihorst, PhD, Annette M May, MD, Anna Frey, MD, Ulrike Kohlweyer, PhD, Justus Duyster, MD PhD, Manfred Jung, PhD, Monika Engelhardt, MD PhD, Ralph Wäsch, MD PhD

Blood (2015) 126 (23): 4260.

https://doi.org/10.1182/blood.V126.23.4260.4260

Published: 2015

Journal Articles

Influence of Different Components of the Tumor Microenvironment on Human Patient-Derived Lymphoma Cell Engraftment in Immmunodeficient Mice

Cordula Tschuch, PhD, Kerstin Klingner, Dorothee Lenhard, Cyrill Rentsch, MD PhD, Christian Wetterauer, Lukas Bubendorf, MD, Tatjana Vlajndic, MD, Milena Pantic, PhD, Lisa K Isbell, MD, Nikolas von Bubnoff, MD, Teppo Haapaniemi, PhD, Julia B. Schueler, DVM, PhD

Blood (2015) 126 (23): 1459.

https://doi.org/10.1182/blood.V126.23.1459.1459

Published: 2015

Journal Articles

Impact of Comorbidities and Prospective Functional Geriatric Assessment Tools (CF-GA) As an Aide to Understand Outcome, Therapy Tolerance, Side Effects and Clinical Trial Eligibility in Multiple Myeloma (MM) Patients (pts)

Alexander Zober, MD, Mandy Möller, Sandra-Maria Dold, Gabriele Ihorst, PhD, Stefanie Hieke, PhD, Jochen Knaus, Milena Pantic, PhD, Barbara Deschler-Baier, MD, Stefan Knop, Hermann Einsele, Christian Langer, Lars-Olof Muegge, MD, Wolfram Poenisch, MD, Justus Duyster, MD PhD, Martin Schumacher, PhD, Ralph M. Waesch, MD PhD, Monika Engelhardt, MD PhD

Blood (2015) 126 (23): 5616.

https://doi.org/10.1182/blood.V126.23.5616.5616

Published: 2015

Journal Articles

Conditional Survival Analysis of 816 Multiple Myeloma (MM) Patients Constitutes a Different Way to Provide More Specifically Determined Prognosis

Maximilian Schinke, Inga Promny, MD, Stefanie Hieke, PhD, Johannes M. Waldschmidt, MD, Gabriele Ihorst, PhD, Milena Pantic, PhD, Justus Duyster, MD, Ralph Wäsch, MD PhD, Martin Schuhmacher, PhD, Monika Engelhardt, MD

Blood (2015) 126 (23): 2091.

https://doi.org/10.1182/blood.V126.23.2091.2091

Published: 2015

Journal Articles

Establishment and Characterization of a Panel of Patient-Derived Acute Leukemia Mouse Models As Emerging Platform for Translational Research

Eva Oswald, PhD, Gabriele Greve, Kerstin Klingner, Benedikt Hammerich, Dorothee Lenhard, Milena Pantic, PhD, Michael Luebbert, MD, Julia B. Schueler, DVM, PhD

Blood (2015) 126 (23): 2538.

https://doi.org/10.1182/blood.V126.23.2538.2538

Published: 2015

Journal Articles

First Results of the Interdisciplinary Comprehensive Cancer Center Freiburg (CCCF) Tumor Board (TB) Multiple Myeloma (MM) Assessing TB-Questions, TB-Advice Adherence, TB-Satisfaction of Patients, Participants and Referring Physicians, Inclusion of Difficult-to-Treat-MM Pts in Clinical Trials (CT) and Patient Outcome

Ricarda Selder, Masa Pandurevic, Mandy-Deborah Möller, Johannes Waldschmidt, MD, Milena Pantic, Georg W. Herget, Karl Henne, Annette May, Martina Kleber, MD, Josefina Udi, MD, Gabriele Ihorst, Rainer Bredenkamp, Werner Vach, Justus Duyster, MD, Ralph Wäsch, MD, Monika Engelhardt, MD

Blood (2014) 124 (21): 2635.

https://doi.org/10.1182/blood.V124.21.2635.2635

Published: 2014

Journal Articles

Importance and Determinants of Comorbidities, Functional Limitations and Multiple Myeloma (MM)-Specific Risk Factors: Further Development of an Improved and Weighted MM-Risk Score (Freiburg Comorbidity Index [FCI])

Anne-Saskia Domm, Stefanie Hieke, Gabriele Ihorst, Milena Pantic, Bernd Koch, Martina Kleber, MD, Johannes Waldschmidt, MD, Martin Schumacher, PhD, Ralph Wäsch, MD, Monika Engelhardt, MD

Blood (2014) 124 (21): 733.

https://doi.org/10.1182/blood.V124.21.733.733

Published: 2014

Journal Articles

Tracing the development of acute myeloid leukemia in CBL syndrome

Blood (2014) 123 (12): 1883–1886.

https://doi.org/10.1182/blood-2013-10-533844

Published: 2014

Includes: Supplemental data

Journal Articles

Vorinostat (V) In Combination With Bortezomib (B), Doxorubicin (D) and Dexamethasone (D) (VBDD) In Patients With Refractory Or Relapsed Multiple Myeloma: An Interim Phase I/II Analysis

Martina Kleber, Dagmar Wider, Kristina Keller, Barbara Groß, Heike Reinhardt, Dorothee Jakobs, Mandy-Deborah Moeller, Manuela Burbeck, Milena Pantic, Annette May, Manfred Jung, PhD, Ralph Waesch, MD, Monika Engelhardt, MD

Blood (2013) 122 (21): 3202.

https://doi.org/10.1182/blood.V122.21.3202.3202

Published: 2013

Journal Articles

Individual Patient Data Of Conditional Survival Analysis In a Large Cohort Of 816 Multiple Myeloma (MM) Patients Constitutes a Different Way To Identify Patients With Extended Life Expectancy

Martina Kleber, Stefanie Hieke, Milena Pantic, Bernd Koch, Gabriele Ihorst, Ralph Waesch, MD, Philippe Moreau, MD, Martin Schumacher, Monika Engelhardt, MD

Blood (2013) 122 (21): 1745.

https://doi.org/10.1182/blood.V122.21.1745.1745

Published: 2013

Journal Articles

SNP Array Analysis In Unrelated HLA-Matched Transplanted Patients Reveals Loss of Patient- Specific Allele at the Mismatched Locus

Miguel Waterhouse, Dietmar Pfeifer, Milena Pantic, Florian Emmerich, Monika Engelhardt, Hartmut Bertz, PhD, Juergen Finke

Blood (2010) 116 (21): 4692.

https://doi.org/10.1182/blood.V116.21.4692.4692

Published: 2010

Journal Articles

B-Cell Receptor Profiling Suggests a Limited Number of Antigens Involved in the Pathogenesis of Chronic Lymphocytic Leukemia.

Mascha Binder, Fabian Müller, Mareike Frick, Claudia Wehr, Milena Pantic, Dietmar Pfeifer, Renata Pasqualini, Wadih Arap, MD, PhD, Hendrik Veelken, MD, Roland H. Mertelsmann, MD, PhD, Martin Trepel

Blood (2008) 112 (11): 2060.

https://doi.org/10.1182/blood.V112.11.2060.2060

Published: 2008

Journal Articles

Coincidence of Chronic Lymphocytic Leukemia (CLL) and Multiple Myeloma (MM) in One Patient: An Exceptional or Common Event? Summary of 4 Cases at a Single Center.

Justyna Rawluk, MD, Percy Schröttner, MD, Ullrich Denz, MD, Dietmar Pfeifer, MD, Milena Pantic, MD, Hendrik Veelken, MD, Monika Engelhardt, MD

Blood (2006) 108 (11): 4980.

https://doi.org/10.1182/blood.V108.11.4980.4980

Published: 2006

Journal Articles

Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays

Dietmar Pfeifer, Milena Pantic, Ilona Skatulla, Justyna Rawluk, Clemens Kreutz, Uwe M. Martens, Paul Fisch, Jens Timmer, Hendrik Veelken

Blood (2006) 109 (3): 1202–1210.

https://doi.org/10.1182/blood-2006-07-034256

Published: 2006

Includes: Supplemental data

Journal Articles

High Resolution Genomic Profiling in CLL Using SNP Oligonucleotide Microarrays.

Justyna Rawluk, Dietmar Pfeifer, Milena Pantic, Hendrik Veelken

Blood (2005) 106 (11): 2946.

https://doi.org/10.1182/blood.V106.11.2946.2946

Published: 2005

NARROW

Identification of Epigenetic Modifiers Essential for Growth and Survival of AML1/ETO-Positive Leukemia

The Fanconi Anemia-Associated Protein NIPA Is Essential for the Nuclear Abundance of FANCD2

Minimal Residual Disease (MRD) Analysis Using Multiparametric Flow Cytometry (MFC) and Identification of Differences in Subpopulations Using Next Generation Sequencing (NGS) in the Bone Marrow (BM) of Multiple Myeloma (MM) Patients (pts)

Implantation of Patient-Derived Acute Leukemia Cells into the Hematopoietic Niche of Immunocompromised Mice Favors Faithful Recapitulation of the Disseminated Growth of Human Leukemia

Identification of a Novel Chromosomal Translocation t(11;16)(q23;q22) Fusing MLL to Enhancer of mRNA Decapping (EDC)-4 in Smoldering Acute Myeloid Leukemia

Results of an Open, Non-Comparative, Phase I/II Investigator Initiated Trial (IIT) in Relapsed or Refractory Multiple Myeloma Patients Using Vorinostat, Bortezomib, Doxorubicin and Dexamethasone (VBDD)

Influence of Different Components of the Tumor Microenvironment on Human Patient-Derived Lymphoma Cell Engraftment in Immmunodeficient Mice

Impact of Comorbidities and Prospective Functional Geriatric Assessment Tools (CF-GA) As an Aide to Understand Outcome, Therapy Tolerance, Side Effects and Clinical Trial Eligibility in Multiple Myeloma (MM) Patients (pts)

Conditional Survival Analysis of 816 Multiple Myeloma (MM) Patients Constitutes a Different Way to Provide More Specifically Determined Prognosis

Establishment and Characterization of a Panel of Patient-Derived Acute Leukemia Mouse Models As Emerging Platform for Translational Research

Importance and Determinants of Comorbidities, Functional Limitations and Multiple Myeloma (MM)-Specific Risk Factors: Further Development of an Improved and Weighted MM-Risk Score (Freiburg Comorbidity Index [FCI])

Tracing the development of acute myeloid leukemia in CBL syndrome

Vorinostat (V) In Combination With Bortezomib (B), Doxorubicin (D) and Dexamethasone (D) (VBDD) In Patients With Refractory Or Relapsed Multiple Myeloma: An Interim Phase I/II Analysis

Individual Patient Data Of Conditional Survival Analysis In a Large Cohort Of 816 Multiple Myeloma (MM) Patients Constitutes a Different Way To Identify Patients With Extended Life Expectancy

SNP Array Analysis In Unrelated HLA-Matched Transplanted Patients Reveals Loss of Patient- Specific Allele at the Mismatched Locus

B-Cell Receptor Profiling Suggests a Limited Number of Antigens Involved in the Pathogenesis of Chronic Lymphocytic Leukemia.

Coincidence of Chronic Lymphocytic Leukemia (CLL) and Multiple Myeloma (MM) in One Patient: An Exceptional or Common Event? Summary of 4 Cases at a Single Center.

Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays

High Resolution Genomic Profiling in CLL Using SNP Oligonucleotide Microarrays.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only